In connection with the transaction, $2.0 million of the remaining balance of the note has been secured against the Company’s ...
RenX Enterprises, Inc. ('RenX” or the 'Company”) (NASDAQ: RENX), formerly known as Safe and Green Development Corporation, ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
Completion of the Go-Public Transaction: On November 4, 2025, Summit completed its reverse takeover transaction of Eagle Royalties Ltd., and the Corporation’s common shares commenced trading on the ...
"We are pleased with the strong support from our and Anywhere's stockholders in approving this transaction," said Robert Reffkin, Founder and Chief Executive Officer of Compass. "Today's outcome ...
Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...
Compass, Inc. (NYSE: COMP) ("Compass") and Anywhere Real Estate Inc. (NYSE: HOUS) ("Anywhere") announce that stockholders of each company ...
-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...
The financial industry groups in China have officially put out a joint warning saying that real-world asset tokenization (RWA ...
Shanghai Fosun Pharmaceutical Group Co. will acquire a controlling stake in a Chinese company that developed the country’s ...
January 2026 AEDT / 5 January 2026 ESTCompany Announcements Office Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000 Overview In response to media speculation, SGH Ltd confirms ...